A Study of the Mitogenic Effects of Serotonergic Receptors
血清素受体促有丝分裂作用的研究
基本信息
- 批准号:7334769
- 负责人:
- 金额:$ 29.26万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2007
- 资助国家:美国
- 起止时间:2007-01-01 至 2009-12-31
- 项目状态:已结题
- 来源:
- 关键词:8-Hydroxy-2-(di-n-propylamino)tetralinAccountingActivated LymphocyteAddressAffectAgonistAnimalsAntibodiesAntigen-Presenting CellsAutoimmune DiseasesBackBacteriaBinding SitesBiological ModelsCD4 Positive T LymphocytesCell CommunicationCell Culture SystemCell LineCellsChimeric ProteinsCloningComplexConfusionDataDoctor of PhilosophyEmotionalEnsureErgot AlkaloidsGenerationsGraft RejectionGrowthGrowth FactorHelper-Inducer T-LymphocyteHumanImmune responseImmune systemKnowledgeLeadLiteratureLymphocyteMessenger RNANatureNeoplastic LymphocyteNeurotransmittersPathway interactionsPersonal SatisfactionPhenotypePlantsPolymerase Chain ReactionPopulationProcessProteinsPublishingRNA SplicingRaceReceptor InhibitionRegulationReportingResearch PersonnelRoleSerotoninSerotonin Receptor 5-HT1ASignal TransductionSignal Transduction PathwaySmall Interfering RNASourceSynaptic TransmissionSystemT-Cell ProliferationT-LymphocyteTechniquesTranscriptTryptophanTryptophan 5-monooxygenaseVertebratesautocrinebasecell growthcell typecytokinedesignimmunological synapseinhibitor/antagonistknock-downnovelnovel therapeuticspreventprogramsreceptorresearch studyresponseserotonin receptor
项目摘要
Serotonin and its 14 cognate receptors have been well-characterized over the years, yet the data
produces a confusing picture regarding their functionality. To large extent, the functional attributes of the
receptors apparently depend upon the specific cell type in which they are expressed. This study is designed
to characterize the role of serotonin and several different responding receptors in the stimulation and
regulation of lymphocytes. Our preliminary data has established the presence of serotonin in this system
and show that the receptors are functionally active. Pharmacological anomalies with the 5-HT 1A receptor
have led us to the discovery of a novel chimeric mRNA that encodes a putative fusion protein containing the
first third of the 1A protein. Based on our preliminary data three specific aims are proposed that are
designed to fundamentally characterize the serotonin pathways in lymphocytes. The first aim is intended to
explore whether serotonin is an autocrine survival factor in neoplastic lymphocytes and to expand our
knowledge of the role of serotonin in the activation and differentiation of primary naive helper T cells. The
second aim of the proposal is intended to functionally characterize the novel 1A-fusion transcript identified in
the lymphocytes. The last aim of the proposal is designed to address the mechanism of action of the
serotonergic signals that are transduced through its cognate receptors. For this aim, we will dissect the
relevant signal transduction pathways associated with the 5-HT 1B receptor in a T cell line and in primary T
cells.
Basically, this proposal is designed to explore the role of serotonin (a neurotransmitter, well-known for its
involvement in the control of emotional responses) in mounting immune responses. We hypothesize that
serotonin is a critical regulator of the immune system. Understanding the nature and role of the serotonergic
receptors in the immune system may lead to the advent of new therapeutic strategies to combat autoimmune
disease and treat the problems associated with transplant rejection.
多年来,5-羟色胺及其14个同源受体已得到很好的表征,但是数据
就其功能产生令人困惑的图片。在很大程度上,功能属性
受体显然取决于表达的特定细胞类型。这项研究是设计的
表征5-羟色胺和几种不同反应受体在刺激中的作用
调节淋巴细胞。我们的初步数据已经在该系统中确定了5-羟色胺
并表明受体在功能上是活跃的。 5-HT 1A受体的药理异常
导致我们发现了一种新型的嵌合mRNA,该mRNA编码了一个假定的融合蛋白
1a蛋白的第一三分之一。根据我们的初步数据,提出了三个特定目标
旨在从根本上表征淋巴细胞中的5-羟色胺途径。第一个目的是
探索5-羟色胺是否是肿瘤淋巴细胞中的自分泌生存因子并扩展我们
了解5-羟色胺在原代幼稚辅助T细胞激活和分化中的作用的知识。这
该提案的第二个目的旨在在功能上表征新的1a融合笔录
淋巴细胞。该提案的最后目的旨在解决
通过其同源受体转导的血清素能信号。为此,我们将剖析
与T细胞系中的5-HT 1B受体相关的相关信号转导途径和一级T中的相关信号转导途径
细胞。
基本上,该建议旨在探索5-羟色胺的作用(神经递质,以其著名
参与控制情绪反应的控制)在安装免疫反应中。我们假设这一点
5-羟色胺是免疫系统的关键调节剂。了解血清素能的性质和作用
免疫系统中的受体可能会导致新的治疗策略来对抗自动免疫
疾病并治疗与移植排斥相关的问题。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
BRADFORD A JAMESON其他文献
BRADFORD A JAMESON的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('BRADFORD A JAMESON', 18)}}的其他基金
A Study of the Mitogenic Effects of Serotonergic Receptors
血清素受体促有丝分裂作用的研究
- 批准号:
7209326 - 财政年份:2007
- 资助金额:
$ 29.26万 - 项目类别:
A Study of the Mitogenic Effects of Serotonergic Receptors
血清素受体促有丝分裂作用的研究
- 批准号:
7556785 - 财政年份:2007
- 资助金额:
$ 29.26万 - 项目类别:
Rationally Designed Inhibitors of Cytotoxic T Cells
合理设计的细胞毒性 T 细胞抑制剂
- 批准号:
6545623 - 财政年份:2002
- 资助金额:
$ 29.26万 - 项目类别:
CD4 MIMETICS AS A POTENTIAL TREATMENT FOR MS
CD4 模拟物作为多发性硬化症的潜在治疗方法
- 批准号:
2892426 - 财政年份:1998
- 资助金额:
$ 29.26万 - 项目类别:
CD4 MIMETICS AS A POTENTIAL TREATMENT FOR MS
CD4 模拟物作为多发性硬化症的潜在治疗方法
- 批准号:
6187181 - 财政年份:1998
- 资助金额:
$ 29.26万 - 项目类别:
CD4 MIMETICS AS A POTENTIAL TREATMENT FOR MS
CD4 模拟物作为多发性硬化症的潜在治疗方法
- 批准号:
6032310 - 财政年份:1998
- 资助金额:
$ 29.26万 - 项目类别:
CD4 MIMETICS AS A POTENTIAL TREATMENT FOR MS
CD4 模拟物作为多发性硬化症的潜在治疗方法
- 批准号:
2676707 - 财政年份:1998
- 资助金额:
$ 29.26万 - 项目类别:
相似国自然基金
签字注册会计师动态配置问题研究:基于临阵换师视角
- 批准号:72362023
- 批准年份:2023
- 资助金额:28 万元
- 项目类别:地区科学基金项目
全生命周期视域的会计师事务所分所一体化治理与审计风险控制研究
- 批准号:72372064
- 批准年份:2023
- 资助金额:40 万元
- 项目类别:面上项目
会计师事务所数字化能力构建:动机、经济后果及作用机制
- 批准号:72372028
- 批准年份:2023
- 资助金额:42.00 万元
- 项目类别:面上项目
会计师事务所薪酬激励机制:理论框架、激励效应检验与优化重构
- 批准号:72362001
- 批准年份:2023
- 资助金额:28.00 万元
- 项目类别:地区科学基金项目
环境治理目标下的公司财务、会计和审计行为研究
- 批准号:72332002
- 批准年份:2023
- 资助金额:165.00 万元
- 项目类别:重点项目
相似海外基金
Neutrophil derived proteinases abolish the IFNG signature in NSCLC
中性粒细胞衍生的蛋白酶消除 NSCLC 中的 IFNG 特征
- 批准号:
10717448 - 财政年份:2023
- 资助金额:
$ 29.26万 - 项目类别:
Emerging role of tumor-derived exosomes in immune modulation and breast cancer health disparity.
肿瘤源性外泌体在免疫调节和乳腺癌健康差异中的新作用。
- 批准号:
10726647 - 财政年份:2023
- 资助金额:
$ 29.26万 - 项目类别:
Antenatal Anxiety and Dyadic Immune Risk(ADIR Study)
产前焦虑和二元免疫风险(ADIR 研究)
- 批准号:
10561867 - 财政年份:2023
- 资助金额:
$ 29.26万 - 项目类别:
The push and pull of inflammation on HIV susceptibility: impact of host variation in CD101 and AXL
炎症对 HIV 易感性的推拉:CD101 和 AXL 宿主变异的影响
- 批准号:
10546199 - 财政年份:2022
- 资助金额:
$ 29.26万 - 项目类别:
The push and pull of inflammation on HIV susceptibility: impact of host variation in CD101 and AXL
炎症对 HIV 易感性的推拉:CD101 和 AXL 宿主变异的影响
- 批准号:
10664009 - 财政年份:2022
- 资助金额:
$ 29.26万 - 项目类别: